From: CSF3R, SETBP1 and CALR mutations in chronic neutrophilic leukemia
No. | Diagnosis | Gender/Age | Hb (g/L) | WBC (×109/L) | ANC (×109/L) | PLT (×109/L) | Spleen (cm,LCM) | Karyotypes | CSF3R | SETBP1 | CALR | JAK2V617F | Treatment | Survival (month) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | CNL | M/80 | 120 | 27.19 | 25.42 | 91 | 3 | 46,XY,t(1,7) (p32,q11)[10] | T618I | D874N | wt | wt | Hydroxyurea | 52 |
2 | CNL | M/64 | 123 | 86.83 | ND | 394 | 0 | 46,XY[5] | T618I | D868N | wt | wt | Hydroxyurea | 5+ |
3 | CNL | F/77 | 125 | 35.68 | 25.92 | 351 | 4 | 46,XY[20] | T618I | G870S | wt | wt | Hydroxyurea | 22+ |
4 | CNL | F/49 | 104 | 85.61 | 79.47 | 20 | 6 | 46,XX[20] | T618I | I871T | wt | wt | Hydroxyurea | 13+ |
5 | CNL | M/70 | 86 | 146.77 | 121.82 | 104 | 15 | ND | T618I | I871T | wt | wt | Hydroxyurea | 17 |
6 | CNL | M/43 | 55 | 112.65 | 101.1 | 98 | 10 | 46,XY[5] | T618I | D868N | wt | wt | Hydroxyurea | 4+ |
7 | CNL | F/69 | 102 | 57.40 | 40.16 | 231 | 6 | 46,XX[12] | T618I | wt | c.1154-1155insTTGTC | wt | Hydroxyurea | 10 |
8 | CNL | M/45 | 119 | 32.76 | 28.73 | 286 | 6 | 46,XY[9] | T618I | wt | wt | wt | Hydroxyurea | 32 |
9 | MGUS-CNL | M/46 | 63 | 65.30 | 60.7 | 101 | 7 | 46,XY[2] | wt | wt | wt | wt | Hydroxyurea | 6+ |
10 | MGUS-CNL | F/52 | 121 | 26.53 | 19.94 | 170 | 3 | 46,XX[20] | wt | wt | wt | wt | Hydroxyurea | 27+ |